NALFX | RSLCX | NALFX / RSLCX | |
Total Expense Ratio | 1.03 | 1.30 | 79% |
Annual Report Gross Expense Ratio | 1.03 | 1.30 | 79% |
Fund Existence | 43 years | 23 years | - |
Gain YTD | 21.951 | 8.440 | 260% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 272M | 79.1B | 0% |
Annual Yield % from dividends | 1.71 | 0.40 | 427% |
Returns for 1 year | 17.64 | 10.07 | 175% |
Returns for 3 years | -0.84 | 33.96 | -2% |
Returns for 5 years | 24.01 | 19.16 | 125% |
Returns for 10 years | 66.98 | 41.67 | 161% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETCHX | 29.77 | 0.14 | +0.47% |
Eventide Healthcare & Life Sciences C | |||
FTVAX | 34.97 | 0.15 | +0.43% |
FullerThaler Behav Md-Cp Val A | |||
REEBX | 59.47 | 0.13 | +0.22% |
American Funds EUPAC R2E | |||
HIOCX | 18.26 | 0.03 | +0.16% |
Hartford International Opportunities C | |||
HJIGX | 15.10 | -0.01 | -0.07% |
Hardman Johnston Intl Gr Fd Instl Shr |